Close Menu
Truth Republican
  • Home
  • News
  • Politics
  • Business
  • Guns & Gear
  • Healthy Tips
  • Prepping & Survival
  • Videos
Facebook X (Twitter) Instagram
Truth Republican
  • Home
  • News
  • Politics
  • Business
  • Guns & Gear
  • Healthy Tips
  • Prepping & Survival
  • Videos
Newsletter
Truth Republican
You are at:Home»News»FDA approves first twice-yearly injection that prevents HIV infection
News

FDA approves first twice-yearly injection that prevents HIV infection

Buddy DoyleBy Buddy DoyleJune 19, 2025No Comments2 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp
FDA approves first twice-yearly injection that prevents HIV infection
Share
Facebook Twitter LinkedIn Pinterest Email

NEWYou can now listen to Fox News articles!

The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent HIV, the creator of the drug, Gilead Sciences, announced on Wednesday.

Sold under the name Yeztugo, the company’s injectable HIV-1 capsid inhibitor (lenacapavir) reduces the risk of sexually acquired HIV in adults and adolescents.

“This is a historic day in the decades-long fight against HIV,” said Daniel O’Day, chairman and CEO of California-based Gilead Sciences, in a press release.

ALZHEIMER’S DISEASE COULD BE PREVENTED BY ANTIVIRAL DRUG ALREADY ON MARKET

The medicine, which only needs to be administered twice a year, has shown “remarkable outcomes in clinical studies,” as Gilead claims it could transform HIV prevention.

The drug is given as an injectable under the skin that the body then slowly absorbs. Individuals must have a negative HIV-1 test prior to starting the treatment.

In large trials last year, the drug was not only nearly 100% effective in its prevention of HIV, but proved superior to once-daily oral medication like Truvada, another drug by Gilead.

A pharmacist holds a vial of lenacapavir

The journal Science named lenacapavir its 2024 “Breakthrough of the Year.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Lenacapavir uses a multi-stage approach that distinguishes it from other approved antiviral medications. 

Man at doctor's appointment

“While most antivirals act on just one stage of viral replication, lenacapavir is designed to inhibit HIV at multiple stages of its lifecycle,” states the press release from Gilead.

For more Health articles, visit www.foxnews.com/health

“Yeztugo is one of the most important scientific breakthroughs of our time and offers a very real opportunity to help end the HIV epidemic,” O’Day said in the press release.

The most commonly reported adverse reactions during clinical trials included injection site reactions, headache and nausea, according to the company.

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleTop 10 Most Bizarre Guns & Weapons You Won’t Believe Exist!
Next Article Discounted college tuition for illegal immigrants policy leads DOJ to sue Kentucky

Related Articles

Trump congratulates Ivy League school after M deal to restore federal funding: ‘Woke is officially DEAD’

Trump congratulates Ivy League school after $50M deal to restore federal funding: ‘Woke is officially DEAD’

July 31, 2025
Trump’s ‘Liberation Day’ tariffs could hit a snag in court today. Here’s what to know

Trump’s ‘Liberation Day’ tariffs could hit a snag in court today. Here’s what to know

July 31, 2025
Mamdani, Cuomo clash over who is better at supporting law enforcement after Manhattan mass shooting

Mamdani, Cuomo clash over who is better at supporting law enforcement after Manhattan mass shooting

July 31, 2025
Reno, Nevada casino shooting remains a mystery as police reveal suspect fired 80 shots

Reno, Nevada casino shooting remains a mystery as police reveal suspect fired 80 shots

July 31, 2025
Apparent AI mistakes force two judges to retract separate rulings

Apparent AI mistakes force two judges to retract separate rulings

July 31, 2025
‘Duck Dynasty’ stars Willie and Korie Robertson share the hard-won lessons of decades-long marriage

‘Duck Dynasty’ stars Willie and Korie Robertson share the hard-won lessons of decades-long marriage

July 31, 2025
Smokey the Bear arrests man for allegedly stealing his signs in Florida to sell on Facebook: ‘Dumb criminals’

Smokey the Bear arrests man for allegedly stealing his signs in Florida to sell on Facebook: ‘Dumb criminals’

July 31, 2025
Army helicopter that crashed with commercial plane in DC was flying above altitude limit: NTSB

Army helicopter that crashed with commercial plane in DC was flying above altitude limit: NTSB

July 31, 2025
Navy calls off search for missing sailor assigned to USS George Washington near Australia

Navy calls off search for missing sailor assigned to USS George Washington near Australia

July 31, 2025
Don't Miss
Trump congratulates Ivy League school after M deal to restore federal funding: ‘Woke is officially DEAD’

Trump congratulates Ivy League school after $50M deal to restore federal funding: ‘Woke is officially DEAD’

WOW! A BUNCH of new GUNS just came out!

WOW! A BUNCH of new GUNS just came out!

Trump hits Powell as ‘total loser’ after Fed leaves rates unchanged

Trump hits Powell as ‘total loser’ after Fed leaves rates unchanged

Douglas Murray slams NY mayoral nominee Zohran Mamdani, London’s Sadiq Khan: ‘Stay out of foreign policy’

Douglas Murray slams NY mayoral nominee Zohran Mamdani, London’s Sadiq Khan: ‘Stay out of foreign policy’

Latest News
Tell your wife I said so!

Tell your wife I said so!

July 31, 2025
Fed’s favored inflation gauge shows consumer prices rose again in June

Fed’s favored inflation gauge shows consumer prices rose again in June

July 31, 2025
Kamala Harris decision not to run in 2026 opens door to possible second presidential run in 2028

Kamala Harris decision not to run in 2026 opens door to possible second presidential run in 2028

July 31, 2025
Mamdani, Cuomo clash over who is better at supporting law enforcement after Manhattan mass shooting

Mamdani, Cuomo clash over who is better at supporting law enforcement after Manhattan mass shooting

July 31, 2025
Goldman Sachs CEO shares a vital tip for interns to get ahead in their careers

Goldman Sachs CEO shares a vital tip for interns to get ahead in their careers

July 31, 2025
Copyright © 2025. Truth Republican. All rights reserved.
  • Privacy Policy
  • Terms of use
  • Contact

Type above and press Enter to search. Press Esc to cancel.